Business Context and Reporting Period
Company: Diodes Incorporated
Filing Type: Form 8-K (Current Report)
Date of Report: September 22, 2009
Subject: Execution of a new employment agreement and stock award agreement with Dr. Keh-Shew Lu, President and Chief Executive Officer.
Key Financial Metrics
This filing does not report operational financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation terms.
Material Changes and Compensation Terms
On September 22, 2009, the Company entered into a six-year employment agreement with Dr. Keh-Shew Lu, extending his term through May 31, 2015. Key terms include:
- Base Salary: $326,000 annually, subject to Board discretion for increases.
- Stock Awards: Grants of 100,000 shares of Common Stock on April 14 of each year from 2010 through 2015.
- Performance Conditions: Stock installments vest only if the Company achieves specified net sales targets. Unvested shares are forfeited upon termination unless due to death or disability.
- Benefits: Participation in executive bonus plans, reimbursement of business expenses, paid vacation, group health plans, life insurance ($700,000 death benefit), and disability insurance.
- Restrictions: Prohibitions on disclosing trade secrets, engaging in competitive activities, and soliciting employees during employment and for two years thereafter.
Termination Provisions and Risks
The agreement outlines specific severance obligations based on the reason for termination:
- Termination without Cause or for Good Reason:
- One year of continued annual base salary.
- Prorated executive bonus for the fiscal year of termination.
- Continued health plan participation for 18 months.
- Existing stock-based compensation remains governed by applicable award agreements.
- Termination for Cause or without Good Reason:
- Prorated base salary through the date of termination.
- Prorated executive bonus for the fiscal year of termination.
- No additional severance or extended benefits.
Risks and Contingencies: The stock awards are contingent on achieving specific net sales targets. If these targets are not met, granted shares may be forfeited. Additionally, the filing notes that confidential treatment has been requested for portions of the Stock Award Agreement (Exhibit 99.3).
Investor Verification Checklist
- Verify the specific net sales targets required for the vesting of the 100,000 annual stock grants (details redacted in public filing).
- Review the definitions of "Cause" and "Good Reason" in the full Employment Agreement (Exhibit 99.1) to understand severance triggers.
- Confirm the Company's current net sales trajectory against the undisclosed performance thresholds.
- Assess the impact of the $326,000 base salary and potential stock grants on total executive compensation relative to peer companies.